1. MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3


    Shengliang Sun et al, 2020, Cancer Management and Research CrossRef
  2. MicroRNA-505, Suppressed by Oncogenic Long Non-coding RNA LINC01448, Acts as a Novel Suppressor of Glycolysis and Tumor Progression Through Inhibiting HK2 Expression in Pancreatic Cancer
    Zhenglei Xu et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  3. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients
    Guang-Zhi Zhang et al, 2021, Frontiers in Molecular Biosciences CrossRef
  4. Damage-Associated Molecular Patterns Modulation by microRNA: Relevance on Immunogenic Cell Death and Cancer Treatment Outcome
    María Julia Lamberti et al, 2021, Cancers CrossRef
  5. Regulation of Molecular Targets in Osteosarcoma Treatment
    Betul Celik et al, 2022, International Journal of Molecular Sciences CrossRef
  6. Transcription factor ELK1 accelerates aerobic glycolysis to enhance osteosarcoma chemoresistance through miR-134/PTBP1 signaling cascade
    Qiang Zhang et al, 2021, Aging CrossRef
  7. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clinical and Translational Oncology CrossRef